Target intelligence / Profile preview

Ribosomal protein SA pseudogene 69 (RPSAP69)

Target
RPSAP69
Molecular classification
Other (transcribed processed pseudogene), not a receptor, enzyme, transporter, etc.
01

Overview

Ribosomal protein SA pseudogene 69 (RPSAP69) is part of a large family of pseudogenes derived from the ribosomal protein SA gene (RPSA). RPSA encodes a multifunctional protein involved in ribosome assembly and cell surface laminin receptor activity, but RPSAP69 itself does not encode a functional protein and is considered a processed pseudogene. There is no evidence for its involvement in biological processes, drug interaction, clinical biomarker use, or disease association. Unlike some pseudogenes such as RPSAP52 that may regulate parental gene expression as noncoding RNAs in cancer and development, RPSAP69 lacks known regulatory or functional properties. It is not considered a valid therapeutic target, and its mention as such may result from confusion with its parent gene or functional pseudogenes. If structured data for true therapeutic targets is required, RPSAP69 should be excluded unless further research discovers specific noncoding RNA-mediated activity analogous to that found for RPSAP52; as of now, that evidence is absent.

Other names
Ribosomal protein SA pseudogene 69 (HGNC:51922)ENSG00000233487
02

Mechanism of action

None; no drugs target RPSAP69.

03

Biological functions

None established; pseudogenes generally do not produce functional proteins.Some RPSA pseudogenes such as RPSAP52 have been shown to exert regulatory functions at the RNA level, but this is not documented for RPSAP69.
04

Disease associations

None established for RPSAP69.Related pseudogenes (e.g., RPSAP52) have been linked to cancer via noncoding RNA regulatory effects, but there are no documented roles for RPSAP69.
05

Safety considerations

None; not a therapeutic target.
06

Interacting drugs

None; no drugs are reported to interact with RPSAP69.
07

Biomarkers

None; not used as a biomarker.

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 69 (RPSAP69).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 69 (RPSAP69).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call